Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LIN vs MRNA✓SelectedUSD · MRNALIN vs MRNA performance historyLatest closeAs of-0.57%11/18
Stock and ETF performance explorer

LIN vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+65.6%
MRNA return
-20.0%
Excess return
+85.6%
Maximum drawdown
-22.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-0.6%-4.8%+4.3%-0.5%
7D-2.7%-20.9%+18.1%-2.2%
30D+1.7%-13.3%+15.0%+2.0%
3M+7.3%+212.6%-205.2%+1.6%
6M+0.9%+309.0%-308.1%-6.6%
YTD+21.3%+567.3%-546.0%+7.6%
1Y+25.2%+689.7%-664.5%+9.4%
3Y+30.5%+157.4%-127.0%+19.3%
5Y+65.6%-21.7%+87.3%+57.3%
All+65.6%-20.0%+85.6%+57.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling